Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-   A1924 Z-WEHD-FMK1 CitationSummary: Caspase 5 inhibitor,potent,cell-permeable and irreversible A1924 Z-WEHD-FMK1 CitationSummary: Caspase 5 inhibitor,potent,cell-permeable and irreversible
-   A3583 Matrine1 CitationSummary: Alkaloid found in Sophora plant A3583 Matrine1 CitationSummary: Alkaloid found in Sophora plant
-   N2285 Dimethylfraxetin N2285 Dimethylfraxetin
-   B4653 BV611 CitationSummary: Selective inhibitor of IAP proteins B4653 BV611 CitationSummary: Selective inhibitor of IAP proteins
-   B6109 CPI-1189Summary: necrosis factor (TNF) alpha inhibitor B6109 CPI-1189Summary: necrosis factor (TNF) alpha inhibitor
-   C4239 RPI-1Summary: ATP-dependent RET kinase inhibitor C4239 RPI-1Summary: ATP-dependent RET kinase inhibitor
-   B4756 YH239-EESummary: p53-MDM2 antagonist, potent B4756 YH239-EESummary: p53-MDM2 antagonist, potent
-   A4204 JNJ-26854165 (Serdemetan)1 CitationTarget: p53|HDM2 ubiquitin ligaseSummary: P53 activator, blocking Mdm2-p53 interaction A4204 JNJ-26854165 (Serdemetan)1 CitationTarget: p53|HDM2 ubiquitin ligaseSummary: P53 activator, blocking Mdm2-p53 interaction
-   A4200 Apogossypolone (ApoG2)2 CitationTarget: Bcl-2|Bcl-xl|Mcl-1Summary: Bcl-2 inhibitor,nonpeptidic small molecule A4200 Apogossypolone (ApoG2)2 CitationTarget: Bcl-2|Bcl-xl|Mcl-1Summary: Bcl-2 inhibitor,nonpeptidic small molecule
-   A1923 Z-VEID-FMK2 CitationTarget: CaspasesSummary: Caspase-6 inhibitor A1923 Z-VEID-FMK2 CitationTarget: CaspasesSummary: Caspase-6 inhibitor

